Global improvement in genotyping of human papillomavirus DNA: The 2011 HPV LabNet international proficiency study

Journal of Clinical Microbiology

Volumn 52, Issue 2, 2014, Pages 449-459

  Eklund, Carina ^a,b   Forslund, Ola ^a   Wallin, Keng Ling ^c   Dillner, Joakim ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c EQUALIS AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; GENOTYPING TECHNIQUE; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68A; HUMAN PAPILLOMAVIRUS TYPE 68B; NONHUMAN; PLASMID; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VIRUS GENOME; VIRUS STRAIN; WART VIRUS;

DNA, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HEALTH SERVICES RESEARCH; HUMANS; INTERNATIONAL COOPERATION; LABORATORY PROFICIENCY TESTING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY; WORLD HEALTH;

EID: 84893141886     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02453-13     Document Type: Article

References (37)

1. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. 2011. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22:2675-2686. http://dx.doi.org/10.1093/annonc/mdr015.
2. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121:621-632. http://dx.doi.org/10.1002/ijc.22527.
3. Steinau M, Onyekwuluje JM, Scarbrough MZ, Unger ER, Dillner J, Zhou T. 2012. Performance of commercial reverse line blot assays for human papillomavirus genotyping. J. Clin. Microbiol. 50:1539-1544. http://dx.doi.org/10.1128/JCM.06576-11.
4. Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, Snijders PJF, Petry KU, Krüger Kjaer S, Munk C, Iftner T. 2008. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J. Med. Virol. 80:1264-1274. http://dx.doi.org/10.1002/jmv.21191.
5. Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Ho L, Terry G, Liddle S, Wright C, Lyons D, Szarewski A. 2013. Comparing the performance of six human papillomavirus tests in a screening population. Br. J. Cancer 108:908-913. http://dx.doi.org/10.1038/bjc.2013.22.
6. Eklund C, Forslund O, Wallin KL, Zhou T, Dillner J, WHO Human Papillomavirus Laboratory Network. 2012. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J. Clin. Microbiol. 50:2289-2298. http://dx.doi.org/10.1128/JCM.00840-12.
7. Baylis SA, Ma L, Padley DJ, Heath AB, Yu MW, Collaborative Study Group. 2012. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang. 102:204-211. http://dx.doi.org/10.1111/j.1423- 0410.2011.01541.x.
8. Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nübling CM. 2012. FirstWHOInternational Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA. J. Clin. Virol. 55:303-309. http://dx.doi.org/10.1016/j.jcv.2012.08.013.
9. WHO2005.WHOtechnical workshop on the role of laboratory detection of human papillomavirus in global disease prevention and control. 15 to 17 August 2005, Geneva, Switzerland. http://whqlibdoc.who.int/hq/2006/WHO-IVB-06.04-eng. pdf.
10. Ferguson M, Wilkinson DE, Zhou T. 2009. WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine 27:337-347. http://dx.doi.org/10.1016/j.vaccine.2008.10.062.
11. Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J. Clin. Microbiol. 49:3474-3481. http://dx.doi.org/10.1128/JCM.05039-11.
12. WHO Department of Immunization, Vaccines, and Biologicals. 2009. Human papillomavirus laboratory manual, 1st ed. World Health Organization, Geneva, Switzerland. See http://whqlibdoc.who.int/hq/2010/WHO-IVB-10.12-eng.pdf.
13. Wilkinson DE, Baylis SA, Padley D, Heath AB, Ferguson M, Pagliusi SR, Quint WG, Wheeler CM, Collaborative Study Group. 2010. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int. J. Cancer 126:2969-2983. http://dx.doi.org/10.1002/ ijc.25039.
14. Eklund C, Zhou T, Dillner J, WHO Human Papillomavirus Laboratory Network. 2010. Global proficiency study of human papillomavirus genotyping. J. Clin. Microbiol. 48:4147-4155. http://dx.doi.org/10.1128/JCM.00918-10.
15. Snijders PJ, Hogewoning CJ, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MC, Meijer CJ. 2006. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV16, 18, 31 and 33-positive women with normal cytology. Int. J. Cancer 119:1102-1107. http://dx.doi.org/10.1002/ijc.21956.
16. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077-1085. http://dx.doi.org/10.1093/infdis/170.5.1077.
17. Chouhy D, Gil LB, Nocito AL, Wojdyla D, Ornella L, Cittadini J, Gardiol D, Giri AA. 2006. Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses. Int. J. Mol. Med. 18:995-1003.
18. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. 1998. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:3020-3027.
19. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. 1995. Group-specific differentiation between highand low-risk human papillomavirus genotypes by general primermediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol. 33:901-905.
20. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
21. Schmitt M, Dondog B, Waterboer T, Pawlita M. 2008. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5-and GP6-primers. J. Clin. Microbiol. 46: 1050-1059. http://dx.doi.org/10.1128/JCM.02227-07.
22. Söderlund-Strand A, Carlson J, Dillner J. 2009. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J. Clin. Microbiol. 47:541-546. http://dx.doi.org/10.1128/JCM. 02007-08.
23. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B. 2004. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J. Clin. Microbiol. 42:3176-3184. http://dx.doi.org/10.1128/JCM.42.7.3176-3184.2004.
24. van den Brule AJC, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJF. 2002. GP5-/6-PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human pap-illomavirus genotypes. J. Clin. Microbiol. 40:779-787. http://dx.doi.org/10.1128/JCM.40.3.779-787.2002.
25. Stevens MP, Garland SM, Tabrizi SN. 2008. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J. Virol. Methods 147:290-296. http://dx.doi.org/10.1016/j.jviromet.2007.09.018.
26. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512. http://dx.doi.org/10.1128/JCM.44.2.504-512.2006.
27. Burd EM. 2003. Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16:1-17. http://dx.doi.org/10.1128/CMR.16.1.1-17.2003.
28. Coutlée F, Rouleau D, Ghattas G, Hankins C, Vézina S, Coté P, Macleod J, de Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E. 2007. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J. Clin. Microbiol. 45:3821-3823. http://dx.doi.org/10.1128/JCM.01145-07.
29. Kocjan BJ, Poljak M, Seme K. 2010. Universal ProbeLibrary based realtime PCR assay for detection and confirmation of human papillomavirus genotype 52 infections. J. Virol. Methods 163:492-494. http://dx.doi.org/10.1016/j.jviromet. 2009.10.024.
30. Reijans M, Dingemans G, Klaassen CH, Meis JF, Keijdener J, Mulders B, Eadie K, van Leeuwen W, van Belkum A, Horrevorts AM, Simons G. 2008. RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses. J. Clin. Microbiol. 46:1232-1240. http://dx.doi.org/10. 1128/JCM.02294-07.
31. Feng Q, Cherne S, Winer RL, Balasubramanian A, Lee SK, Hawes SE, Kiviat NB, Koutsky LA. 2009. Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J. Clin. Microbiol. 47:547-553. http://dx.doi.org/10.1128/JCM.01707-08.
32. Wieland U, Ritzkowsky A, Stoltidis M, Weissenborn S, Stark S, Ploner M, Majewski S, Jablonska S, Pfister HJ, Fuchs PG. 2000. Communication: papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J. Invest. Dermatol. 115:124-128. http://dx.doi.org/10. 1046/j.1523-1747.2000.00015.x.
33. Nishiwaki M, Yamamoto T, Tone S, Murai T, Ohkawara T, Matsunami T, Koizumi M, Takagi Y, Yamaguchi J, Kondo N, Nishihira J, Horikawa T, Yoshiki T. 2008. Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications. J. Clin. Microbiol. 46:1161-1168. http://dx.doi.org/10.1128/JCM.00793-07.
34. Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. 2007. Real-time Taqman PCR targeting 14 human papilloma virus types. J. Clin. Virol. 40:321-324. http://dx.doi.org/10.1016/j.jcv.2007.09.009.
35. Longuet M, Beaudenon S, Orth G. 1996. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J. Clin. Microbiol. 34:738-744.
36. Reuter S, Delius H, Kahn T, Hofmann B, zur Hausen H, Schwarz E. 1991. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J. Virol. 65:5564-5568.
37. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124:516-520. http://dx.doi.org/10.1002/ijc.24010.